Proteasomal Inhibition Promotes ATP-Binding Cassette Transporter A1 (ABCA1) and ABCG1 Expression and Cholesterol Efflux From Macrophages In Vitro and In Vivo
Author(s) -
Masatsune Ogura,
Makoto Ayaori,
Yoshio Terao,
Tetsuya Hisada,
Maki Iizuka,
Shunichi Takiguchi,
Harumi UtoKondo,
Emi Yakushiji,
Kazuhiro Nakaya,
Makoto Sasaki,
Tomohiro Komatsu,
Hideki Ozasa,
Fumitaka Ohsuzu,
Katsunori Ikewaki
Publication year - 2011
Publication title -
arteriosclerosis thrombosis and vascular biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.007
H-Index - 270
eISSN - 1524-4636
pISSN - 1079-5642
DOI - 10.1161/atvbaha.111.228478
Subject(s) - abca1 , abcg1 , reverse cholesterol transport , in vivo , proteasome , cholesterol , proteasome inhibitor , microbiology and biotechnology , biology , atp binding cassette transporter , protein degradation , efflux , lipoprotein , chemistry , biochemistry , transporter , gene
ATP-binding cassette transporter A1 (ABCA1) and ABCG1 are key molecules in an initial step of reverse cholesterol transport (RCT), a major antiatherogenic property of high-density lipoprotein (HDL). The ubiquitin-proteasome system (UPS) mediates nonlysosomal pathways for protein degradation and is known to be involved in atherosclerosis. However, little is known about the effects of the UPS on these molecules and overall RCT. We therefore investigated whether UPS inhibition affects ABCA1/G1 expression in macrophages and RCT in vitro and in vivo.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom